Ani Pharmaceuticals (ANIP) Gross Profit Growth (3y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Gross Profit Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -35.83% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 44.16% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 37.26% |
| 10 | Ani Pharmaceuticals | 1.71 Bn | 1.40 Bn | 143.88 Mn | 27.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.71% |
| Dec 31, 2025 | 36.35% |
| Sep 30, 2025 | 38.20% |
| Jun 30, 2025 | 52.50% |
| Mar 31, 2025 | 60.16% |
| Dec 31, 2024 | 59.80% |
| Sep 30, 2024 | 45.55% |
| Jun 30, 2024 | 45.08% |
| Mar 31, 2024 | 129.25% |
| Dec 31, 2023 | 33.73% |
| Sep 30, 2023 | 36.58% |
| Jun 30, 2023 | 38.79% |
| Mar 31, 2023 | 35.17% |
| Dec 31, 2022 | 24.27% |
| Sep 30, 2022 | 11.91% |
| Jun 30, 2022 | -0.14% |
| Mar 31, 2022 | -7.50% |
| Dec 31, 2021 | -9.93% |
| Sep 30, 2021 | -7.64% |
| Jun 30, 2021 | -4.99% |